Cross-source evidence timeline
Oxytocin research timeline
Follow 82 selected, directly cited source records from April 17, 1980 through November 16, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.
Source year
2026
Clinical trials
ClinicalTrials.gov record NCT06285396↗
PeptideScanner retained ClinicalTrials.gov record NCT06285396 at 2026-11-16T13:28:59.838Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT06930391↗
PeptideScanner retained ClinicalTrials.gov record NCT06930391 at 2026-11-16T02:15:32.969Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026Literature metadata
Oxytocin and social neuroscience - sexually dimorphic OXTR neurons in mouse preoptic area.↗
PubMed lists PMID 42191115 in Progress in neurobiology as Journal Article, Review, with publication-date metadata of 2026-05-25 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 25, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Oxytocin and autism - A precision medicine framework to unpack mechanisms and evidence.↗
PubMed lists PMID 42144048 in Neuroscience and biobehavioral reviews as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-05-16 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 16, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Beyond lactation: Central oxytocin in maternal mental health and disease.↗
PubMed lists PMID 42002246 in Neuroscience and biobehavioral reviews as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-04-17 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 17, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Oxytocin, sex hormones and brain activity in facial expression processing: A sex-based systematic review.↗
PubMed lists PMID 41707759 in Neuroscience and biobehavioral reviews as Journal Article, Systematic Review, with publication-date metadata of 2026-02-16 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 16, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Rewiring connection: The role of oxytocin in interactive media behavior.↗
PubMed lists PMID 41796877 in Neuroscience and biobehavioral reviews as Journal Article, Review, with publication-date metadata of 2026-03-06 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 6, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Reframing oxytocin as a behavioral flexibility hormone.↗
PubMed lists PMID 41796879 in Neuroscience and biobehavioral reviews as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-03-06 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 6, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
A narrative review on oxytocin at the intersection of sleep, stress, and social behavior.↗
PubMed lists PMID 42093825 in Frontiers in neuroscience as Journal Article, Review, with publication-date metadata of 2026-04-21 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 21, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Role of Oxytocin in Obesity.↗
PubMed lists PMID 42766066 in Current diabetes reports as Journal Article, Review, with publication-date metadata of 2026-09-21 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: September 21, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Oxytocin in chronic pain: From analgesic to biopsychosocial adjuvant - An opinion paper.↗
PubMed lists PMID 41619996 in Neuroscience and biobehavioral reviews as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-01-29 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: January 29, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Opioids and the oxytocin system: Mechanistic interactions altering maternal neuroplasticity.↗
PubMed lists PMID 42876328 in Journal of neuroendocrinology as Journal Article, Review, with publication-date metadata of 2026-10 (month precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: October 2026 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
Context-dependent oxytocin receptor signaling: from molecular architecture to transcript-level receptor engineering.↗
PubMed lists PMID 42903669 in Frontiers in neuroscience as Journal Article, Review, with publication-date metadata of 2026-10-06 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: October 6, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Markers of the maternal oxytocin system and mother-infant bonding during the first postpartum year.↗
PubMed lists PMID 42716459 in Progress in neurobiology as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2026-09-09 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: September 9, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Oxytocin and RAGE signaling at the intersection of social neurodevelopment and inflammation.↗
PubMed lists PMID 42415063 in Journal of translational medicine as Journal Article, Review, with publication-date metadata of 2026-07-07 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: July 7, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Endometrial Preparation Strategies for Frozen Embryo Transfer in Women with Adenomyosis: A Systematic Review of Hormone Replacement Therapy, Gonadotropin-Releasing Hormone Agonist, and Oxytocin Antag…↗
PubMed lists PMID 42799216 in International journal of women's health as Journal Article, Review, with publication-date metadata of 2026-09-21 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: September 21, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Oxytocin facilitates top-down and bottom-up attention to emotional faces in a general and temporal-dependent manner.↗
PubMed lists PMID 41776858 in Psychological medicine as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-03-04 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 4, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Anterior cingulate cortex, anterior insular cortex and altruistic behaviors; a hypothetical role for oxytocin.↗
PubMed lists PMID 42623778 in Hormones and behavior as Journal Article, Review, with publication-date metadata of 2026-08-20 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: August 20, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Current Perspectives on Oxytocin and Alzheimer's Disease-Related Symptoms.↗
PubMed lists PMID 41503900 in Current Alzheimer research as Journal Article, Review, with publication-date metadata of 2026 (year precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 2026 · year precisionAdded to PeptideScanner November 16, 2026Literature metadata
An epigenetic framework for understanding contextual influences on neural and socio-emotional development: Narrative review and case-study of the oxytocin receptor.↗
PubMed lists PMID 41903260 in Developmental cognitive neuroscience as Journal Article, Review, with publication-date metadata of 2026-03-20 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 20, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Translational pathways of oxytocin therapy in schizophrenia: bridging negative symptom domains and neural mechanisms.↗
PubMed lists PMID 42236472 in Translational psychiatry as Journal Article, Review, with publication-date metadata of 2026-06-03 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: June 3, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
[Boosting oxytocin in postpartum depression].↗
PubMed lists PMID 41989096 in Nederlands tijdschrift voor geneeskunde as Journal Article, Randomized Controlled Trial, English Abstract, with publication-date metadata of 2026-04-16 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 16, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Oxytocin beyond social bonding: Advancing neuromodulation, synaptic plasticity, and epigenetic precision in CNS disorders.↗
PubMed lists PMID 41759439 in Neuropeptides as Journal Article, Review, with publication-date metadata of 2026-02-25 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 25, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Oxytocin for chronic pain and acupuncture analgesia.↗
PubMed lists PMID 41666492 in Current opinion in pharmacology as Journal Article, Review, with publication-date metadata of 2026-01-20 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: January 20, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Early life adversity, oxytocin system alterations, and addiction vulnerability: a narrative review.↗
PubMed lists PMID 42126578 in Psychopharmacology as Journal Article, Review, with publication-date metadata of 2026-05-13 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 13, 2026 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT04228289↗
PeptideScanner retained ClinicalTrials.gov record NCT04228289 at 2026-11-16T00:59:19.138Z. Its registry update date was 2026-03-11, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT03899961↗
PeptideScanner retained ClinicalTrials.gov record NCT03899961 at 2026-11-16T00:59:19.138Z. Its registry update date was 2026-02-10, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026Literature metadata
The active monitoring of oxytocin research evidence (AMORE) platform.↗
PubMed lists PMID 41389446 in Psychoneuroendocrinology as Journal Article, Systematic Review, with publication-date metadata of 2025-12-05 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 5, 2025 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT05782816↗
PeptideScanner retained ClinicalTrials.gov record NCT05782816 at 2026-11-16T00:59:19.138Z. Its registry update date was 2026-01-09, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026
Source year
2025
Literature metadata
How factors of the therapeutic alliance interact with oxytocin neurotransmission in psychotherapy.↗
PubMed lists PMID 41458027 in Frontiers in psychiatry as Journal Article, Review, with publication-date metadata of 2025-12-11 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 11, 2025 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT05929339↗
PeptideScanner retained ClinicalTrials.gov record NCT05929339 at 2026-11-16T00:59:19.138Z. Its registry update date was 2025-10-28, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT02505984↗
PeptideScanner retained ClinicalTrials.gov record NCT02505984 at 2026-11-16T00:59:19.138Z. Its registry update date was 2025-02-25, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT03846505↗
PeptideScanner retained ClinicalTrials.gov record NCT03846505 at 2026-11-16T00:59:19.138Z. Its registry update date was 2025-02-21, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026
Source year
2024
Clinical trials
ClinicalTrials.gov record NCT05326776↗
PeptideScanner retained ClinicalTrials.gov record NCT05326776 at 2026-11-16T00:59:19.138Z. Its registry update date was 2024-12-31, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT04028765↗
PeptideScanner retained ClinicalTrials.gov record NCT04028765 at 2026-11-16T00:59:19.138Z. Its registry update date was 2024-04-30, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT02918864↗
PeptideScanner retained ClinicalTrials.gov record NCT02918864 at 2026-11-16T00:59:19.138Z. Its registry update date was 2024-04-05, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026
Source year
2023
Clinical trials
ClinicalTrials.gov record NCT02150954↗
PeptideScanner retained ClinicalTrials.gov record NCT02150954 at 2026-11-16T00:59:19.138Z. Its registry update date was 2023-10-26, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026
Source year
2022
Clinical trials
ClinicalTrials.gov record NCT03140488↗
PeptideScanner retained ClinicalTrials.gov record NCT03140488 at 2026-11-16T00:59:19.138Z. Its registry update date was 2022-12-20, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT04105998↗
PeptideScanner retained ClinicalTrials.gov record NCT04105998 at 2026-11-16T00:59:19.138Z. Its registry update date was 2022-11-10, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT03463993↗
PeptideScanner retained ClinicalTrials.gov record NCT03463993 at 2026-11-16T00:59:19.138Z. Its registry update date was 2022-06-01, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT03138252↗
PeptideScanner retained ClinicalTrials.gov record NCT03138252 at 2026-11-16T00:59:19.138Z. Its registry update date was 2022-05-04, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT02487797↗
PeptideScanner retained ClinicalTrials.gov record NCT02487797 at 2026-11-16T00:59:19.138Z. Its registry update date was 2022-02-11, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026
Source year
2021
Clinical trials
ClinicalTrials.gov record NCT02595749↗
PeptideScanner retained ClinicalTrials.gov record NCT02595749 at 2026-11-16T00:59:19.138Z. Its registry update date was 2021-11-15, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT03929367↗
PeptideScanner retained ClinicalTrials.gov record NCT03929367 at 2026-11-16T00:59:19.138Z. Its registry update date was 2021-05-13, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT03935399↗
PeptideScanner retained ClinicalTrials.gov record NCT03935399 at 2026-11-16T00:59:19.138Z. Its registry update date was 2021-04-05, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026
Source year
2019
Clinical trials
ClinicalTrials.gov record NCT01614093↗
PeptideScanner retained ClinicalTrials.gov record NCT01614093 at 2026-11-16T00:59:19.138Z. Its registry update date was 2019-08-28, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026Regulatory
Federal Register rule 2019-04226↗
The Federal Register published rule 2019-04226, attributed to FDA and its parent HHS department, on 2019-03-13. Its official title is “New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Changes of Sponsorship,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.↗
Added to PeptideScanner November 16, 2026
Source year
2018
Regulatory
Drugs@FDA application ANDA091676↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 091676 with status AP dated 2018-07-13, and names oxytocin among the application record's active ingredients.↗
Added to PeptideScanner November 16, 2026Regulatory
Federal Register rule 2018-06358↗
The Federal Register published rule 2018-06358, attributed to FDA and its parent HHS department, on 2018-03-30. Its official title is “New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Changes of Sponsorship; Change of a Sponsor's Name and Address,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.↗
Added to PeptideScanner November 16, 2026
Source year
2017
Clinical trials
ClinicalTrials.gov record NCT02273115↗
PeptideScanner retained ClinicalTrials.gov record NCT02273115 at 2026-11-16T00:59:19.138Z. Its registry update date was 2017-07-02, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT02508103↗
PeptideScanner retained ClinicalTrials.gov record NCT02508103 at 2026-11-16T00:59:19.138Z. Its registry update date was 2017-06-27, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT00919802↗
PeptideScanner retained ClinicalTrials.gov record NCT00919802 at 2026-11-16T00:59:19.138Z. Its registry update date was 2017-05-23, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026
Source year
2016
Clinical trials
ClinicalTrials.gov record NCT01829516↗
PeptideScanner retained ClinicalTrials.gov record NCT01829516 at 2026-11-16T00:59:19.138Z. Its registry update date was 2016-07-27, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026Regulatory
Federal Register rule 2016-13517↗
The Federal Register published rule 2016-13517, attributed to FDA and its parent HHS department, on 2016-06-08. Its official title is “New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Changes of Sponsorship,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT00790062↗
PeptideScanner retained ClinicalTrials.gov record NCT00790062 at 2026-11-16T00:59:19.138Z. Its registry update date was 2016-04-08, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026
Source year
2015
Regulatory
Federal Register notice 2015-09299↗
The Federal Register published notice 2015-09299, attributed to FDA and its parent HHS department, on 2015-04-22. Its official title is “Determination That OXYTOCIN in 5% Dextrose Injection Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.↗
Added to PeptideScanner November 16, 2026
Source year
2014
Regulatory
Federal Register rule 2014-06131↗
The Federal Register published rule 2014-06131, attributed to FDA and its parent HHS department, on 2014-03-25. Its official title is “Implantation or Injectable Dosage Form New Animal Drugs; Change of Sponsor,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.↗
Added to PeptideScanner November 16, 2026
Source year
2013
Regulatory
Federal Register rule 2013-07542↗
The Federal Register published rule 2013-07542, attributed to FDA and its parent HHS department, on 2013-04-09. Its official title is “New Animal Drugs; Change of Sponsor,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.↗
Added to PeptideScanner November 16, 2026Regulatory
Federal Register rule 2013-06126↗
The Federal Register published rule 2013-06126, attributed to FDA and its parent HHS department, on 2013-03-22. Its official title is “New Animal Drugs; Changes of Sponsor,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.↗
Added to PeptideScanner November 16, 2026Regulatory
Drugs@FDA application ANDA200219↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 200219 with status AP dated 2013-02-13, and names oxytocin among the application record's active ingredients.↗
Added to PeptideScanner November 16, 2026
Source year
2012
Clinical trials
ClinicalTrials.gov record NCT00906347↗
PeptideScanner retained ClinicalTrials.gov record NCT00906347 at 2026-11-16T00:59:19.138Z. Its registry update date was 2012-11-15, and PeptideScanner's reviewed identity mapping was oxytocin.↗
Added to PeptideScanner November 16, 2026Regulatory
Federal Register notice 2012-22195↗
The Federal Register published notice 2012-22195, attributed to FDA and its parent HHS department, on 2012-09-10. Its official title is “Withdrawal of Approval of New Animal Drug Applications; Chorionic Gonadotropin; Naloxone; Oxymorphone; Oxytocin,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.↗
Added to PeptideScanner November 16, 2026Regulatory
Federal Register rule 2012-22196↗
The Federal Register published rule 2012-22196, attributed to FDA and its parent HHS department, on 2012-09-10. Its official title is “New Animal Drugs; Chorionic Gonadotropin; Naloxone; Oxymorphone; Oxytocin,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.↗
Added to PeptideScanner November 16, 2026
Source year
2009
Regulatory
Federal Register notice E9-11628↗
The Federal Register published notice E9-11628, attributed to FDA and its parent HHS department, on 2009-05-19. Its official title is “Novartis Pharmaceuticals Corp. et al.; Withdrawal of Approval of 92 New Drug Applications and 49 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin and Sermorelin.↗
Added to PeptideScanner November 16, 2026
Source year
2008
Regulatory
Drugs@FDA application ANDA077453↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 077453 with status AP dated 2008-01-24, and names oxytocin among the application record's active ingredients.↗
Added to PeptideScanner November 16, 2026
Source year
2004
Regulatory
Federal Register notice 04-15570↗
The Federal Register published notice 04-15570, attributed to FDA and its parent HHS department, on 2004-07-09. Its official title is “Notice of Approval of Abbreviated New Animal Drug Application; Oxytocin Injection,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.↗
Added to PeptideScanner November 16, 2026
Source year
2003
Regulatory
Federal Register rule 03-15618↗
The Federal Register published rule 03-15618, attributed to FDA and its parent HHS department, on 2003-06-20. Its official title is “Dosage Form New Animal Drugs; Change of Sponsor; Technical Amendment,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.↗
Added to PeptideScanner November 16, 2026
Source year
2001
Regulatory
Federal Register notice 01-11620↗
The Federal Register published notice 01-11620, attributed to FDA and its parent HHS department, on 2001-05-09. Its official title is “Purina Mills, Inc., et al.; Withdrawal of Approval of New Animal Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.↗
Added to PeptideScanner November 16, 2026Regulatory
Federal Register rule 01-11621↗
The Federal Register published rule 01-11621, attributed to FDA and its parent HHS department, on 2001-05-09. Its official title is “Animal Drugs, Feeds, and Related Products; Trichlorfon, etc.; Withdrawal of Approval of NADAs,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.↗
Added to PeptideScanner November 16, 2026Regulatory
Federal Register rule 01-11070↗
The Federal Register published rule 01-11070, attributed to FDA and its parent HHS department, on 2001-05-03. Its official title is “Animal Drugs, Feeds, and Related Products; Tylosin Tartrate for Injection, etc.; Withdrawal of Approval of NADAs,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.↗
Added to PeptideScanner November 16, 2026Regulatory
Federal Register notice 01-11071↗
The Federal Register published notice 01-11071, attributed to FDA and its parent HHS department, on 2001-05-03. Its official title is “Elanco Animal Health, A Div. of Eli Lilly & Co. et al.; Withdrawal of Approval of NADAs,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.↗
Added to PeptideScanner November 16, 2026
Source year
2000
Regulatory
Federal Register rule 00-18828↗
The Federal Register published rule 00-18828, attributed to FDA and its parent HHS department, on 2000-07-26. Its official title is “New Animal Drugs; Change of Sponsor,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.↗
Added to PeptideScanner November 16, 2026
Source year
1997
Regulatory
Federal Register notice 97-20871↗
The Federal Register published notice 97-20871, attributed to FDA and its parent HHS department, on 1997-08-07. Its official title is “Sterling Drug, Inc., et al.; Withdrawal of Approval of 28 New Drug Applications, 9 Abbreviated Antibiotic Applications, and 46 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.↗
Added to PeptideScanner November 16, 2026Regulatory
Federal Register notice 97-19065↗
The Federal Register published notice 97-19065, attributed to FDA and its parent HHS department, on 1997-07-21. Its official title is “Babineaux's Veterinary Products, Inc., et al.; Withdrawal of Approval of NADA's,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.↗
Added to PeptideScanner November 16, 2026Regulatory
Federal Register rule 97-19066↗
The Federal Register published rule 97-19066, attributed to FDA and its parent HHS department, on 1997-07-21. Its official title is “Animal Drugs, Feeds, and Related Products,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.↗
Added to PeptideScanner November 16, 2026Regulatory
Federal Register rule 97-16967↗
The Federal Register published rule 97-16967, attributed to FDA and its parent HHS department, on 1997-06-30. Its official title is “Animal Drugs, Feeds, and Related Products; Change of Sponsor,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.↗
Added to PeptideScanner November 16, 2026
Source year
1995
Regulatory
Federal Register rule 95-15241↗
The Federal Register published rule 95-15241, attributed to FDA and its parent HHS department, on 1995-06-22. Its official title is “New Animal Drugs; Change of Sponsor,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.↗
Added to PeptideScanner November 16, 2026
Source year
1985
Regulatory
Drugs@FDA application NDA019185↗
The official Drugs@FDA dataset lists original submission 1 for NDA 019185 with status AP dated 1985-03-29, and names oxytocin among the application record's active ingredients.↗
Added to PeptideScanner November 16, 2026
Source year
1980
Regulatory
Drugs@FDA application NDA018261↗
The official Drugs@FDA dataset lists original submission 1 for NDA 018261 with status AP dated 1980-11-19, and names oxytocin among the application record's active ingredients.↗
Added to PeptideScanner November 16, 2026Regulatory
Drugs@FDA application NDA018248↗
The official Drugs@FDA dataset lists original submission 1 for NDA 018248 with status AP dated 1980-07-09, and names oxytocin among the application record's active ingredients.↗
Added to PeptideScanner November 16, 2026Regulatory
Drugs@FDA application NDA018243↗
The official Drugs@FDA dataset lists original submission 1 for NDA 018243 with status AP dated 1980-04-29, and names oxytocin among the application record's active ingredients.↗
Added to PeptideScanner November 16, 2026Regulatory
Drugs@FDA application NDA018245↗
The official Drugs@FDA dataset lists original submission 1 for NDA 018245 with status AP dated 1980-04-17, and names oxytocin among the application record's active ingredients.↗
Added to PeptideScanner November 16, 2026